Collplant
Rehovot
About Collplant
CollPlant is a regenerative medicine company that focuses on 3D bioprinting of tissues and organs and also develops and commercializes tissue repair products for orthobiologics. The company's products are based on the rhCollagen that is produced with CollPlant’s proprietary plant-based genetic engineering technology. The rhCollagen BioInk is ideal for 3D bioprinting of tissues and organs, and the unique Vergenix line of rhCollagen products contains a soft tissue repair matrix for treating tendinopathy and a wound repair matrix to promote rapid optimal healing of acute and chronic wounds. CollPlant is headquartered in Rehovot, Israel.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Estimated revenue: Less than $1M
- Total funding: $80.2M
- Funding stage: IPO
- Last round: Post-IPO Equity (Feb 2026)
- Ticker: tlv:CLPT
- Website: collplant.com
- Phone: +972 73 2325600
Industries & Categories
3D Printing, 3D Technology, Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/collplant-143240 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.